These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35908584)

  • 1. An expert-driven literature review of "negative" chemicals for developmental neurotoxicity (DNT) in vitro assay evaluation.
    Martin MM; Baker NC; Boyes WK; Carstens KE; Culbreth ME; Gilbert ME; Harrill JA; Nyffeler J; Padilla S; Friedman KP; Shafer TJ
    Neurotoxicol Teratol; 2022; 93():107117. PubMed ID: 35908584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
    Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
    Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Data From In Vitro New Approach Methodologies for Developmental Neurotoxicity.
    Carstens KE; Carpenter AF; Martin MM; Harrill JA; Shafer TJ; Paul Friedman K
    Toxicol Sci; 2022 Apr; 187(1):62-79. PubMed ID: 35172012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
    Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
    Smirnova L; Hogberg HT; Leist M; Hartung T
    ALTEX; 2024; 41(2):152-178. PubMed ID: 38579692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
    Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental neurotoxicity test guidelines: problems and perspectives.
    Tohyama C
    J Toxicol Sci; 2016; 41(Spec):SP69-SP79. PubMed ID: 28250285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
    Tsuji R; Crofton KM
    Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity.
    Hughes S; Hessel EVS
    Crit Rev Toxicol; 2024 May; 54(5):330-343. PubMed ID: 38832580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
    Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
    ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM; Sepehri S; Midali M; Stinckens M; Biesiekierska M; Wolniakowska A; Gatzios A; Rundén-Pran E; Reszka E; Marinovich M; Vanhaecke T; Roszak J; Viviani B; SenGupta T
    Arch Toxicol; 2024 May; 98(5):1271-1295. PubMed ID: 38480536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity.
    Chesnut M; Hartung T; Hogberg H; Pamies D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Per- and Polyfluoroalkyl Substances (PFAS)
    Carstens KE; Freudenrich T; Wallace K; Choo S; Carpenter A; Smeltz M; Clifton MS; Henderson WM; Richard AM; Patlewicz G; Wetmore BA; Paul Friedman K; Shafer T
    Chem Res Toxicol; 2023 Mar; 36(3):402-419. PubMed ID: 36821828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines.
    Kamata S; Hashiyama R; Hana-Ika H; Ohkubo I; Saito R; Honda A; Anan Y; Akahoshi N; Noguchi K; Kanda Y; Ishii I
    Toxicol In Vitro; 2020 Dec; 69():104999. PubMed ID: 32949729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical testing strategies for predicting health hazards to children.
    Lamb JC; Brown SM
    Reprod Toxicol; 2000; 14(2):83-94. PubMed ID: 10825671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How neurobehavior and brain development in alternative whole-organism models can contribute to prediction of developmental neurotoxicity.
    Collins ES; Hessel EVS; Hughes S
    Neurotoxicology; 2024 May; 102():48-57. PubMed ID: 38552718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.